- Home
- VHI vs MRVI Comparison
VHI vs MRVI Comparison
Compare VHI & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VHI
- MRVI
- Stock Information
- Founded
- VHI 1932
- MRVI 2020
- Country
- VHI United States
- MRVI United States
- Employees
- VHI N/A
- MRVI N/A
- Industry
- VHI Major Chemicals
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- VHI Industrials
- MRVI Health Care
- Exchange
- VHI Nasdaq
- MRVI Nasdaq
- Market Cap
- VHI 709.1M
- MRVI 676.6M
- IPO Year
- VHI N/A
- MRVI 2020
- Fundamental
- Price
- VHI $23.77
- MRVI $5.23
- Analyst Decision
- VHI Sell
- MRVI Buy
- Analyst Count
- VHI 1
- MRVI 10
- Target Price
- VHI $20.00
- MRVI $10.28
- AVG Volume (30 Days)
- VHI 21.0K
- MRVI 1.8M
- Earning Date
- VHI 03-06-2025
- MRVI 02-25-2025
- Dividend Yield
- VHI 1.39%
- MRVI N/A
- EPS Growth
- VHI N/A
- MRVI N/A
- EPS
- VHI 3.08
- MRVI N/A
- Revenue
- VHI $2,076,900,000.00
- MRVI $276,920,000.00
- Revenue This Year
- VHI $19.58
- MRVI N/A
- Revenue Next Year
- VHI $11.92
- MRVI $1.52
- P/E Ratio
- VHI $7.47
- MRVI N/A
- Revenue Growth
- VHI 10.99
- MRVI N/A
- 52 Week Low
- VHI $12.12
- MRVI $4.28
- 52 Week High
- VHI $41.75
- MRVI $11.56
- Technical
- Relative Strength Index (RSI)
- VHI 52.48
- MRVI 48.29
- Support Level
- VHI $20.40
- MRVI $4.38
- Resistance Level
- VHI $24.55
- MRVI $6.21
- Average True Range (ATR)
- VHI 1.22
- MRVI 0.41
- MACD
- VHI 0.42
- MRVI -0.05
- Stochastic Oscillator
- VHI 81.20
- MRVI 46.45
About VHI Valhi Inc.
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment. Chemicals Segment is a producer and marketer of value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to a wide variety of products, including paints, plastics, paper, fibers, and ceramics. Geographically the company operates in the United States, Germany, Canada, Norway, and Belgium, where the majority of revenue comes from the United States.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.